DMII Drugs Made In America Acquisition II Corp.
Blank Checks · Nasdaq · SEC CIK 2040475 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | — | — | — | — | — | — | — |
| SG&A expense | $77,010 | $112,227 | $132,030 | $235,472 | $155,513 | $38,073 | $59,327 |
| Operating income | -$77,010 | -$112,227 | -$132,030 | -$235,472 | -$155,513 | -$38,073 | -$59,327 |
| Net income | $4.62M | $4.40M | $4.34M | $4.33M | -$46,158 | -$38,073 | -$59,327 |
| EPS (diluted) | — | — | — | — | — | — | — |
| Balance sheet | |||||||
| Cash & equivalents | $118,232 | $174,974 | $347,720 | $223 | $315,087 | $4,394 | $6,991 |
| Current assets | $139,657 | $217,823 | $351,761 | $26,037 | $896,356 | — | — |
| Total assets | $518.72M | $514.10M | $509.73M | $504.96M | $501.01M | — | — |
| Current liabilities | $643,418 | $644,574 | $666,285 | $300,864 | $677,345 | — | — |
| Short-term debt | — | $450,000 | $450,000 | — | — | — | — |
| Total liabilities | $18.14M | $18.14M | $18.17M | $17.80M | $18.18M | — | — |
| Shareholders' equity | -$18.00M | -$17.93M | -$17.81M | -$17.77M | -$17.28M | -$214,119 | -$176,046 |
| Shares outstanding | 13.70M | 13.70M | 13.70M | 13.70M | 15.57M | — | — |
| Cash flow statement | |||||||
| Operating cash flow | -$56,742 | -$172,746 | -$102,503 | -$314,864 | -$690,726 | -$2,597 | -$10,044 |
| Investing cash flow | — | — | — | $0 | — | — | — |
| Financing cash flow | $0 | $0 | $450,000 | $0 | — | — | — |
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.